PhD Researchers
임예솔_(박사급인력).png
임예솔 Yesol Yim, PhD Researcher, bearbag@naver.com
의료빅데이터, 의료인공지능, 머신러닝, 디지털헬스

· 수상이력

2026 한빛사 4회 선정
2026 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2026 제1회 의학계열 융합 심포지엄:Magnolia Health Nexus 경희 메디컬 루키상 수상
2025 Research Fellow, Massachusetts General Hospital & Harvard Medical School
2025 Khreative U+ SDGs 연구 지원 선정

· 논문

2026
15. Maternal Opioid Use and Subsequent Risk of Allergic Diseases in Children: Emulation of Target Trials Using the Korean Nationwide Birth Cohort. Allergy. 2026 (제 1저자; IF 12.0)
14. Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program. Prog Cardiovasc Dis. 2026 (제 1저자; IF 7.6) 
13. National trends of metabolically healthy and unhealthy obesity before and during the COVID-19 pandemic, 2007 to 2021: A representative serial study in South Korea. Medicine (Baltimore). 2026 (제 1저자; IF 1.4)
12. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nat Med. 2026 (제 1저자; IF 50.0)
 
2025
11. Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021. Cell Rep Med. 2025 (제 1저자; IF 10.6)
10. Methodological considerations in CKM risk stratification: age validation of PREVENT-authors' reply. Lancet Reg Health West Pac. 2025 (제 1저자; IF 8.1)
9. Biomarkers for Alzheimer's disease across diverse biological domains: an umbrella review and evidence map. J Adv Res. 2025 (제 1저자; IF 13.0)
8. Family history of non-communicable diseases and the risk of cardiovascular-kidney-metabolic syndrome. Sci Rep. 2025 (제 1저자; IF 3.9)
7. Global estimates of vaccine-associated narcolepsy from 1967 to 2023. Sci Rep. 2025 (제 1저자; IF 3.9)
6. Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database. World J Pediatr. 2025 (제 1저자; IF 3.6)
5. National Trends in Asthma Prevalence among Adolescents in South Korea, 2007-2023: A National Representative Serial Study. Int Arch Allergy Immunol. 2025 (제 1저자; IF 2.5)
4. Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011-2021: a representative longitudinal serial study. Lancet Reg Health West Pac. 2025 (제 1저자; IF 7.6)
3. Long-term trends and patterns in ultra-processed food consumption among Korean adults from 1998 to 2022. Sci Rep. 2025 (제 1저자; IF 4.6)
 
2024
2. Sex-Specific and Long-Term Trends of Asthma, Allergic Rhinitis, and Atopic Dermatitis in South Korea, 2007-2022: A Nationwide Representative Study. Int Arch Allergy Immunol. 2024 (제 1저자; IF 2.5)
1. Longitudinal trends in depression, suicidal ideation, and suicide attempts by family structure in South Korean adolescents, 2009-2022: A nationally representative serial study. Asian J Psychiatr. 2024 (제 1저자; IF 3.8)
조혜수_(박사급인력).png
조혜수 Hyesu Jo, PhD Researcher, prejhs2@gmail.com
정밀의료학, 규제과학, 의료빅데이터, 디지털헬스, 의료정보학

· 수상이력

2025 한빛사 3회 선정
2025 의료정보학회장상
2025 ISPEs 아시아약물역학컨퍼런스 Full Scholarship 선정
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 제5회 고황스콜라포스터학술제 대상
2024 Engineering in Biomedical and Rehabilitation & Home Conference [EBRC&HOME] Best Poster Paper Award
2024 Khreative U+ SDGs 연구 지원 선정
2024 인공지능융합혁신인재양성 자율과제 선정

· 논문

2026
29. GBD 2023 Asia Chronic Respiratory Disease Collaborators. Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Respir Med. 2026 (제 1저자; IF 32.8)
28. National Trends in the Prevalence of Suicide Attempts Among Adolescents by Self-Perceived Weight, 2005-2023: A Nationwide Representative Study in South Korea. Psychiatry Investig. 2026 (제 1저자; IF 1.8)

2025
27. Global epidemiology of vaccine-associated intussusception in children and adolescents, 1968 to 2024: An international pharmacovigilance study. Medicine (Baltimore). 2025 (제 1저자; IF 1.4)
26. Global burden of TNF-α inhibitors associated demyelinating diseases: A global disproportionality analysis. Medicine (Baltimore). 2025 (제 1저자; IF 1.4)
25. Burden of post-acute sequelae of COVID-19 in patients with type 2 diabetes: a binational cohort study in South Korea and Japan. Int J Infect Dis. 2025 (제 1저자; IF 4.3)
24. Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis. Sci Rep. 2025 (제 1저자; IF 3.9)
23. Global estimates of vaccine-associated narcolepsy from 1967 to 2023. Sci Rep. 2025 (제 1저자; IF 4.3)
22. Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study. Clin Exp Allergy. 2025 (제 1저자; IF 6.3)
21. Global burden of vaccine-associated Raynaud's phenomenon, 1968-2024: A comprehensive analysis of the pharmacovigilance database. Eur J Clin Pharmacol. 2025 (제 1저자; IF 2.4)
20. Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis. Eur J Clin Pharmacol. 2025 (제 1저자; IF 2.4)
19. Global and Regional Burden of Vaccine-Associated Transverse Myelitis and Potentially Associated With Vaccines From 1967 to 2023: An Analysis of the International Pharmacovigilance Data. J Med Virol. 2025 (제 1저자; IF 6.3)
18. Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023. Sci Rep. 2025 (제 1저자; IF 4.6)
17. TOP10-SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions. Allergy. 2025 (제 1저자; IF 12.6)
16. Global Burden of Vaccine-Associated Cerebrovascular Venous Sinus Thrombosis, 1968-2024: A Critical Analysis From the WHO Global Pharmacovigilance Database. J Korean Med Sci. 2025 (제 1저자; IF 3.0)
15. Nationwide Trends in Screen Time and Associated Risk Factors by Family Structures Among Adolescents, 2008-2022: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2025 (제 1저자; IF 3.5)
14. Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases. Eur J Clin Pharmacol. 2025 (제 1저자; IF 2.4)
13. Use of Biologics to Treat Asthma during Pregnancy and Adverse Events in Pregnant Women and Newborns: A Global Pharmacovigilance Analysis. Int Arch Allergy Immunol. 2025; (제 1저자; IF 2.5)
12. Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns. J Affect Disord. 2025 (제 1저자; IF 4.9)
11. Biologics Use for Psoriasis during Pregnancy and Its Related Adverse Outcomes in Pregnant Women and Newborns: Findings from WHO Pharmacovigilance Study. Int Arch Allergy Immunol. 2025 (제 1저자; IF 2.5)
10. Global Estimates of Vaccine-Associated Hepatic Autoimmune Disorders and Their Related Vaccines, 1968-2024: An International Analysis of the WHO Pharmacovigilance Database. Int Arch Allergy Immunol. 2025 (제 1저자; IF 4.1)
9. Global Estimates of Vaccine-Associated Hepatic Autoimmune Disorders and Their Related Vaccines, 1968-2024: An International Analysis of the WHO Pharmacovigilance Database. Int Arch Allergy Immunol. 2025 (제 1저자; IF 2.5)
8. Nationwide trends in sadness, suicidal ideation, and suicide attempts among multicultural and monocultural adolescents in South Korea during the COVID-19 pandemic, 2011-2022. World J Pediatr. 2024 (제 1저자; IF 3.6)
7. National trends in adolescents' mental health by income level in South Korea, pre- and post-COVID-19, 2006-2022. Sci Rep. 2024 (제 1저자; IF 3.8)
6. Sex-Specific and Long-Term Trends of Asthma, Allergic Rhinitis, and Atopic Dermatitis in South Korea, 2007-2022: A Nationwide Representative Study. Int Arch Allergy Immunol. 2025 (제 1저자; IF 2.5)

2024
5. Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database. Int J Rheum Dis. 2024 (제 1저자; IF 2.4)
4. Association of Soda Drinks and Fast Food with Allergic Diseases in Korean Adolescents: A Nationwide Representative Study. Int Arch Allergy Immunol. 2024 (제 1저자; IF 2.5)
3. Global and regional burden of vaccine-induced thrombotic thrombocytopenia, 1969-2023: Comprehensive findings with critical analysis of the international pharmacovigilance database. Eur J Haematol. 2024 (제 1저자; IF 3.1)
2. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
1. National prevalence of atopic dermatitis in Korean adolescents from 2009 to 2022. Sci Rep. 2024 (제 1저자; IF 4.6)
손예준3.jpg
손예준 Yejun Son, PhD Researcher, dlstod9981@naver.com
정밀의료학, 디지털헬스, 의료빅데이터, 인공지능, 메타분석

· 수상이력

2026 아산사회복지재단 보건의료정책분야 장학생 선발 (박사)
​2025 Research Fellow, New York University
2025 한빛사 5회 선정
2025 평통장학재단 장학생 선발
2025 제 6회 고황스콜라 포스터 학술제 / 발표 우수상 수상
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 한국연구재단 이공분야 학술연구지원사업 (석사과정생연구장려금지원) 선정 / 연구책임자
2024 ISPEs 아시아약물역학컨퍼런스 Scholarship 선정
2024 평통장학재단 장학생 선발
​2024 인공지능융합혁신인재양성 자율과제 선정 / 팀리더
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더

· 논문

2026
42. Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study. Nat Med. 2026 (제 1 저자; IF 50.0)
41. Gestational Diabetes Mellitus and Adverse Maternal and Neonatal Health Outcomes: an Umbrella review of Meta-Analyses. Obes Rev. 2026 (교신저자; IF 7.4)
40. Global Incidence and Prevalence of Trigeminal Neuralgia, 1945-2024: A Systematic Review and Meta-Regression Analysis. J Clin Neurol. 2026 (제 1 저자; IF 3.1)
39. Association between triglyceride glucose-body mass index and early-onset hypertension in South Korea: a nationwide cross-sectional study (2007-2023). Endocrine. 2026 (제 1 저자; IF 2.9)
38. Global Prevalence of Spinal Muscular Atrophy in 204 Countries and Territories, 1960-2024: A Systematic Review and Bayesian Modeling Study. Pediatr Neurol. 2026 (제 1 저자; IF 2.1)

2025
37. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nat Med. 2025 (제 1 저자; IF 58.7)
36. Biomarkers for Alzheimer’s disease across diverse biological domains: an umbrella review and evidence map. J Adv Res. 2025 (제 1 저자; IF 13.0)
35. Global prevalence of congenital color vision deficiency among children and adolescents, 1932-2022. Ophthalmology. 2025 (제 1 저자; IF 9.5)
34. Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011-2021: a representative longitudinal serial study. Lancet Reg Health West Pac. 2025 (제 1 저자; IF 7.6)
33. Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea. J Med Virol. 2025 (제 1 저자; IF 6.8)
32. Post-Acute Sequelae of COVID-19 on Alopecia Areata in Individuals With Mental Illness in South Korea and Japan: A Binational Population-Based Cohort Study. J Med Virol. 2025 (제 1 저자; IF 6.8)
31. Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study. J Med Virol. 2025 (제 1 저자; IF 6.8)
30. Efficacy and safety of glucagon-like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials. Diabetes Obes Metab. 2025 (교신저자; IF 5.7)
29. Global, regional, and national burden of cervical cancer in 2022 and projections to 2050: a population-based analysis of GLOBOCAN. Int J Gynecol Cancer. 2025 (제 1 저자; IF 4.7)
28. National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022. Sci Rep. 2025 (제 1 저자; IF 4.6)
27. Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023. Sci Rep. 2025 (제 1 저자; IF 4.6)
26. Prevalence of Current, Daily, and Heavy Smokers Among Adolescents in 97 Countries: A Global Population-Based Study. J Adolesc Health. 2025 (교신저자; IF 4.5) 
25. Effects of photobiomodulation on multiple health outcomes: an umbrella review of randomized clinical trials. Syst Rev. 2025 (제 1 저자; IF 3.9)
24. Temporal trends and patterns in suicidal ideation among adolescents in 23 countries from 2003 to 2021. Sci Rep. 2025 (제 1 저자; IF 3.9)
2​3. Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database. World J Pediatr. 2025 (제 1 저자; IF 3.6)
22. Nationwide Trends in Screen Time and Associated Risk Factors by Family Structures Among Adolescents, 2008-2022: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2025 (제 1 저자; IF 3.5)
21. Global burden of brain and central nervous system cancer in 185 countries, and projections up to 2050: a population-based systematic analysis of GLOBOCAN 2022. J Neurooncol. 2025 (제 1 저자; IF 3.1)
20. Correlation of Income Instability With 12 Non-Communicable Disease Risks in Korea: A Prospective Cohort Study. J Korean Med Sci. 2025 (제 1 저자; IF 3.0)
19. Global, Regional, and National Burden of Pharyngeal Cancer and Projections to 2050 in 185 Countries: A Population-Based Systematic Analysis of GLOBOCAN 2022. J Korean Med Sci. 2025 (제 1 저자; IF 3.0)
18. Non-Linear Association Between Physical Activities and Type 2 Diabetes in 2.4 Million Korean Population, 2009-2022: A Nationwide Representative Study. J Korean Med Sci. 2025 (제 1 저자; IF 3.0)
17. Dose-response association between physical activity and diagnosed hypertension in 2.4 million Korean population: Korea Community Health Survey 2009-2022. Clin Hypertens. 2025 (교신저자; IF 2.6)
16. Global Prevalence of Combustible Cigarettes and Noncombustible Nicotine or Tobacco Products Use Among Adolescents, 2014-2021. J Korean Med Sci. 2025 (제 1 저자; IF 2.3)
15. Cardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002-2022: A population-based cohort study. Medicine (Baltimore). 2025 (제 1 저자; IF 1.4)

2024
14. Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan. J Med Virol. 2024 (제 1 저자; IF 12.7)
13. Machine Learning-Based Prediction of Suicidal Thinking in Adolescents by Derivation and Validation in 3 Independent Worldwide Cohorts: Algorithm Development and Validation Study. J Med Internet Res. 2024 (제 1 저자; IF 7.4)
12. National trends of allergic diseases and pandemic-related factors among individuals with obesity in South Korea: A nationwide representative serial study, 2005-2021. Heliyon. 2024 (제 1 저자; IF 4.0)
11. Longitudinal trends in depression, suicidal ideation, and suicide attempts by family structure in South Korean adolescents, 2009-2022: A nationally representative serial study. Asian J Psychiatr. 2024 (교신저자; IF 3.8)
10. Global association of secondhand smoke exposure locations and smoking behaviour among adolescents in 99 countries. Acta Paediatr. 2024 (제 1 저자; IF 3.8)
9. Association Between Sociodemographic Factors and Vaccine Acceptance for Influenza and SARS-CoV-2 in South Korea: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
8. Sex-Specific Trends in the Prevalence of Osteoarthritis and Rheumatoid Arthritis From 2005 to 2021 in South Korea: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
7. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
6. Comparison of national trends in physical activity among adolescents before and during the COVID-19 pandemic: A nationally representative serial study in South Korea. Heliyon. 2024 (제 1 저자; IF 3.4)
5. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019. Eur Rev Med Pharmacol Sci. 2024 (제 1 저자; IF 3.3)
4. Racial Discrimination and Multiple Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Med Princ Pract. 2024 (제 1 저자; IF 2.9)
3. Association of Soda Drinks and Fast Food with Allergic Diseases in Korean Adolescents: A Nationwide Representative Study. Int Arch Allergy Immunol. 2024 (제 1 저자; IF 2.5)
2. Temporal changes in smoking prevalence among adolescents across 23 countries. Acta Paediatr. 2024 (제 1 저자; IF 2.4)
1. Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses. Pediatr Cardio . 2024 (제 1 저자; IF 1.5)
adqeadzcad.jpg
이경민 Kyeongmin Lee, PhD Researcher, dlrudals0502@naver.com
규제과학, 의료빅데이터, 디지털헬스, 의료정보학

· 수상이력

2025 한빛사 4회 선정
2025 평통여성장학재단 장학생 선발
2025 ISPEs 아시아약물역학컨퍼런스 Scholarship 선정
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 평통여성장학재단 장학생 선발

· 논문

2025
14. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. (제 1저자; IF 39.3)
13. Effectiveness of the live zoster vaccine in patients with type 2 diabetes: A nationwide emulated target trial. Clin Microbiol Infect. (제 1저자; IF 10.9)         
12. Global burden of antidepressant-associated seizures from 1967 to 2023: A comparative analysis of the international pharmacovigilance database. J Affect Disord. 2025 (제 1 저자; IF 4.9)
11. Adverse drug reaction patterns of GLP-1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database. Diabetes Obes Metab. 2025 (제 1 저자; IF 5.4)

2024
10. Global burden of vaccine-associated angioedema and their related vaccines, 1967-2023: Findings from the global pharmacovigilance database. Allergy. 2024 (제 1 저자; IF 12.7)
9. Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database. J Med Virol. 2024 (제 1 저자; IF 12.7)
8. Associations between weight-control methods and depression among Korean adolescents: a study based on a national dataset. Nutr Res Pract. 2024 (제 1 저자; IF 2.0)
7. National trends in thyroid disease and COVID-19 pandemic-related factors, 1998-2021: A nationwide representative study in South Korea. Heliyon. 2024 (제 1 저자; IF 3.4)
6. National Trends in the Prevalence of Self-Perceived Overweight Among Adolescents Between 2005 and 2022: Nationwide Representative Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
5. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database. Med Princ Pract. 2024 (교신저자; IF 2.9)
4. Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database. Asian J Psychiatr. 2024 (제 1 저자; IF 3.8)
3. Association between glucagon-like peptide-1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database. Diabetes Obes Metab. 2024 (제 1 저자; IF 5.4)
2. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023. Sci Rep. 2024 (제 1 저자; IF 4.6)
1. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023. J Med Virol. 2024 (제 1 저자; IF 6.8)
zxcasdqwe.png
김소은 Soeun Kim, PhD Researcher, soeun9342@naver.com
의료데이터사이언스, 디지털헬스, 의료빅데이터, 인공지능

· 수상이력

2026 Research Fellow, New York University
2026 한빛사 8회 선정
2026 아산사회복지재단 보건의료정책분야 장학생 선발 (박사)
2026 Khreative U+ S-FUN(Star FacUlty Nurturing) 해외 연구연수 지원 선정
2025 평통여성장학재단 장학생 선발
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 평통여성장학재단 장학생 선발
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더

· 논문

2026
25. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nat Med. 2026 (제 1저자; IF 50.0)
24. Deep learning-based survival outcomes of REBOA vs resuscitative thoracotomy in trauma: a nationwide cohort study in South Korea. Int J Surg. 2026 (제 1저자; IF 10.3)

2025
23. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050. Lancet Respir Med. 2025 (제 1저자; IF 38.7)
22. A Multimodal Predictive Model for Chronic Kidney Disease and Its Association With Vascular Complications in Patients With Type 2 Diabetes: Model Development and Validation Study in South Korea and the U.K. Diabetes Care. 2025 (제 1저자; IF 16.6)
21. Method-specific suicide mortality rates among older adults in 47 countries and territories, 1996-2021, with projections to 2050: a global time series and modelling study. Lancet Healthy Longev. 2025 (제 1저자; IF 14.6)
20. Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990-2021, with projections up to 2040: a global time-series analysis and modelling study. Lancet Healthy Longev. 2025 (제 1저자; IF 13.4)
19. Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021. Cell Rep Med. 2025 (제 1저자; IF 10.6)
18. Global burden of anxiety, depression, self-harm (1990-2021) and the impact of COVID-19 pandemic. J Affect Disord. 2025 (제 1저자; IF 4.9)
17. Global Prevalence of Functional Abdominal Pain Disorder among Children and Adolescents According to the Rome III and IV Criteria: A Systematic Review and Meta-Analysis. Gut Liver. 2025 (제 1저자; IF 3.6)
16. Global cancer mortality among children, adolescents, and young adults from 77 countries, 1990-2021: a global time-series analysis and modelling study. World J Pediatr. 2025 (제 1저자; IF 3.6)
15. Method-specific suicide mortality rates among older adults in 47 countries and territories, 1996-2021, with projections to 2050: a global time series and modelling study. Lancet Healthy Longev. 2025 (제 1저자; IF 14.6)
14. A Multimodal Predictive Model for Chronic Kidney Disease and Its Association With Vascular Complications in Patients With Type 2 Diabetes: Model Development and Validation Study in South Korea and the U.K. Diabetes Care. 2025 (제 1저자; IF 16.6)
13. Global, Regional, and National Trends in Maternal Mortality Ratio Across 37 High Income Countries From 1990 to 2021, With Projections up to 2050: A Comprehensive Analysis From the WHO Mortality Database. J Korean Med Sci. 2025 (제 1저자; IF 3.0)
12. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050. Lancet Respir Med. 2025 (제 1저자; IF 38.7)
11. Machine Learning-Based Prediction of Substance Use in Adolescents in Three Independent Worldwide Cohorts: Algorithm Development and Validation Study. J Med Internet Res. 2025 (제 1저자; IF 7.4)
10. Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990-2021, with projections up to 2040: a global time-series analysis and modelling study
 Lancet Healthy Longev. 2025 (제 1저자; IF 13.4)
9. Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study. EClinicalMedicine. 2024 (제 1저자; IF 9.6)

2024
8. Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database. J Korean Med Sci. 2024 (교신저자; IF 3.0)
7. Global Incidence and Prevalence of Chronic Rhinosinusitis: A Systematic Review. Clin Exp Allergy. 2024. (제 1저자; IF 6.3)
6. National Trends in the Prevalence of Unmet Health Care and Dental Care Needs During the COVID-19 Pandemic: Longitudinal Study in South Korea, 2009-2022. JMIR Public Health Surveill. 2024. (제 1저자; IF 3.5)
5. Psychosocial alterations during the COVID-19 pandemic and the global burden of anxiety and major depressive disorders in adolescents, 1990-2021: challenges in mental health amid socioeconomic disparities. World J Pediatr. 2024. (제 1저자; IF 6.1)
4. Global public concern of childhood and adolescence suicide: a new perspective and new strategies for suicide prevention in the post-pandemic era. World J Pediatr. 2024. (제 1저자; IF 6.1)

2023
3. Global incidence and prevalence of eosinophilic esophagitis, 1976-2022, and projections to 2037: a post-hoc analysis. Clin Gastroenterol Hepatol. 2023. (제 1저자; IF 12.6)
2. National and regional trends in the prevalence of type 2 diabetes and associated risk factors among Korean adults, 2009-2021. Sci Rep. 2023. (제 1저자; IF 4.6)
1. National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea. J Med Virol. 2023. (제 1저자; IF 20.693)
슬라이드2.PNG
박재유 Jaeyu Park, PhD Researcher, qkrwodb980@gmail.com
디지털헬스, 의료빅데이터, 인공지능, 머신러닝, 의료정보학

· 수상이력

2026 한빛사 10회 선정
2026 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2025-2026 KHU Presidential Research Fellowship
2025 Research Fellow, New York University 
2025 아산사회복지재단 보건의료정책분야 장학생 선발 (박사)
2025 제2회 미래 규제과학 신진연구자 최우수상 수상
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 아산사회복지재단 보건의료정책분야 장학생 선발 (석사)
2024 ISPEs 아시아약물역학컨퍼런스 Full Scholarship 선정
2024 제 27회 규제과학혁신연구센터 국제공동 심포지엄 / 최우수 포스터상 수상
​2024 제 31회 대한기초의학 학술대회 / 우수 포스터상 수상
2024 인공지능융합혁신인재양성 자율과제 선정 / 팀리더
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 대한비만학회 춘계학술대회 우수구연상 수상
2023 인공지능융합혁신인재양성 자율과제 선정 

· 논문

2026
56. Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Respir Med. 2026 (제 1저자; IF 32.8)
55. Maternal Opioid Use and Subsequent Risk of Allergic Diseases in Children: Emulation of Target Trials Using the Korean Nationwide Birth Cohort. Allergy. 2026 (교신저자; IF 12.0)
54. National trends of unmet healthcare needs and risk factors by household income level, 2010 to 2022: A Nationwide cross-sectional study in South Korea. Medicine (Baltimore). 2026 (제 1저자; IF 1.5)

2025
53. TOP10-SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions. Allergy. 2025 (제 1저자; IF 12.6)
52. Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study. Clin Exp Allergy. 2025 (제 1저자; IF 5.2)
51. Global Burden of Drug-Induced Severe Cutaneous Adverse Reactions Associated With 33 Classes of Antibiotics (1968-2024): An Analysis of International Pharmacovigilance Reports. Clin Exp Allergy. 2025 (제 1저자; IF 5.2)
50. Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea. J Med Virol. 2025 (제 1저자; IF 4.6)
49. Post-Acute Sequelae of COVID-19 on Alopecia Areata in Individuals With Mental Illness in South Korea and Japan: A Binational Population-Based Cohort Study. J Med Virol. 2025 (제 1저자; IF 4.6)
48. Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study. J Med Virol. 2025 (제 1저자; IF 4.6)
47. National trends in the unmet healthcare needs among patients with hypertension or type 2 diabetes mellitus in Korea from 2009 to 2023. Sci Rep. 2025 (제 1저자; IF 3.8)
46. Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis. Sci Rep. 2025 (제 1저자; IF 3.8)
45. Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023. Sci Rep. 2025 (제 1저자; IF 3.8)
44. Artificial intelligence models predicting abnormal uterine bleeding after COVID-19 vaccination. Sci Rep. 2025 (제 1저자; IF 3.8)
43. Development and Validation of a Machine Learning Algorithm for Predicting Diabetes Retinopathy in Patients With Type 2 Diabetes: Algorithm Development Study. JMIR Med Inform. 2025 (제 1저자; IF 3.1)
42. Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases. Eur J Clin Pharmacol. 2025 (제 1저자; IF 2.4)
41. Global Burden of Vaccine-Associated Cerebrovascular Venous Sinus Thrombosis, 1968-2024: A Critical Analysis From the WHO Global Pharmacovigilance Database. J Korean Med Sci. 2025 (제 1저자; IF 2.3)
40. Association of Unmet Healthcare Needs With Depressive Symptoms and COVID-19 Pandemic-Related Factors Among Adults, 2009-2022: A Nationwide Study in Korea. J Korean Med Sci. 2025 (제 1저자; IF 2.3)
39. Global burden of TNF-α inhibitors associated demyelinating diseases: A global disproportionality analysis. Medicine (Baltimore). 2025 (제 1저자; IF 1.4)
38. National trends in the prevalence of hypertension and diabetes stratified by sleep duration in South Korea, 2009-2022: A nationwide cross-sectional study: Trends and association of sleep duration in hypertension and diabetes. Medicine (Baltimore). 2025 (제 1저자; IF 1.4)

2024
37. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024 (제 1저자; IF 16.6)
36. Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multi-nationwide cohort study from South Korea, Japan, and the UK. Clin Mol Hepatol. 2024 (제 1저자; IF 14.0)
35. Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
34. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
33. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK. J Med Virol. 2024 (제 1저자; IF 12.7)
32. National trends in counseling for stress and depression and COVID-19 pandemic-related factors among adults, 2009-2022: a nationwide study in South Korea: Stress and depression and pandemic. Psychiatry Res. 2024 (제 1저자; IF 11.3)
31. Comorbid health outcomes in patients with schizophrenia: an umbrella review of systematic reviews and meta-analyses. Mol Psychiatry. 2024 (제 1저자; IF 9.6)
30. National trends in alcohol consumption, smoking, suicide attempts, and COVID-19 pandemic-related factors among South Korean adolescents, 2012-2022. Asian J Psychiatr. 2024 (제 1저자; IF 9.5)
29. Risks of chronic urticaria following SARS-CoV-2 infection: binational population-based cohort studies from South Korea and Japan. J Allergy Clin Immunol Pract. 2024 (교신저자; IF 9.4)
28. Machine Learning-Based Prediction of Suicidality in Adolescents With Allergic Rhinitis: Derivation and Validation in 2 Independent Nationwide Cohorts. J Med Internet Res. 2024 (제 1저자; IF 7.4)
27. Nationwide trends in sadness, suicidal ideation, and suicide attempts among multicultural and monocultural adolescents in South Korea during the COVID-19 pandemic, 2011-2022. World J Pediatr. 2024 (제 1저자; IF 6.1)
26. Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969-2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database. J Stroke. 2024 (제 1저자; IF 6.0)
25. National prevalence of atopic dermatitis in Korean adolescents from 2009 to 2022. Sci Rep. 2024 (제 1저자; IF 4.6)
24. National prevalence and trends in food labeling awareness, comprehension, usage, and COVID-19 pandemic-related factors in South Korea, 2014–2022. Sci Rep. 2024 (제 1저자; IF 4.6)
23. National trends in rheumatoid arthritis and osteoarthritis prevalence in South Korea, 1998–2021. Sci Rep. 2024 (제 1저자; IF 4.6)
22. Prenatal and postnatal exposure to antibiotics and risk of food allergy in the offspring: A nationwide birth cohort study in South Korea. Pediatr Allergy Immunol. 2024 (제 1저자; IF 4.4; Editor Choice)
21. Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: A nationwide birth cohort study in South Korea. Psychiatry Res. 2024 (제 1저자; IF 4.2)
20. Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database. Allergy Asthma Immunol Res. 2024 (제 1저자; IF 4.1)
19. National trends of allergic diseases and pandemic–related factors among individuals with obesity in South Korea: A nationwide representative serial study, 2005–2021. Heliyon. 2024 (제 1저자; IF 4.0)
18. Global burden of vaccine-associated uveitis and their related vaccines, 1967-2023. Br J Ophthalmol. 2024 (제 1저자; IF 3.8)
17. Predictive model for abdominal liposuction volume in patients with obesity using machine learning in a longitudinal multi-center study in Korea. Sci Rep. 2024 (제 1저자; IF 3.8)
16. National trends in adolescents' mental health by income level in South Korea, pre- and post-COVID-19, 2006-2022. Sci Rep. 2024 (제 1저자; IF 3.8)
15. Global public concern of childhood and adolescence suicide: a new perspective and new strategies for suicide prevention in the post-pandemic era. World J Pediatr. 2024 (제 1저자; IF 3.6)
14. Sex-Specific Trends in the Prevalence of Osteoarthritis and Rheumatoid Arthritis From 2005 to 2021 in South Korea: Nationwide Cross-Sectional Study.  JMIR Public Health Surveill. 2024 (제 1저자; IF 3.5)
13. Comparison of national trends in physical activity among adolescents before and during the COVID-19 pandemic: A nationally representative serial study in South Korea. Heliyon. 2024 (제 1저자; IF 3.4)
12. National trends in thyroid disease and COVID-19 pandemic-related factors, 1998-2021: A nationwide representative study in South Korea. Heliyon. 2024 (제 1저자; IF 3.4)
11. National trends in the prevalence of hepatitis B and C in South Korea, before and during the COVID-19 pandemic (2007-2021)–a nationwide representative study. Eur Rev Med Pharmacol Sci. 2024 (제 1저자; IF 3.3)
10. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019. Eur Rev Med Pharmacol Sci. 2024 (제 1저자; IF 3.3)
9. Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database. J Korean Med Sci. 2024 (제 1저자; IF 3.0)
8. National Trends in Allergic Rhinitis and Chronic Rhinosinusitis and COVID-19 Pandemic-Related Factors in South Korea, from 1998 to 2021. Int Arch Allergy Immunol. 2024 (교신저자; IF 2.8; Editor Choice)
7. National Trends and Prevalence of Atopic Dermatitis and Pandemic-Related Factors among Korean Adults, 2007–2021. Int Arch Allergy Immunol. 2024 (제 1저자; IF 2.8)
6. Association of Soda Drinks and Fast Food with Allergic Diseases in Korean Adolescents: A Nationwide Representative Study. Int Arch Allergy Immunol. 2024 (교신저자; IF 2.8)
5. Global estimates of vaccine-associated hepatic autoimmune disorders and their related vaccines, 1968-2024: An international analysis of the WHO pharmacovigilance database. Int Arch Allergy Immunol. 2024 (제 1저자; IF 2.5)
4. Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database. Int J Rheum Dis. 2024 (제 1저자; IF 2.4)

2023
3. National trends in depression and suicide attempts and COVID-19 pandemic-related factors, 1998–2021: A nationwide study in South Korea. Asian J Psychiatr. 2023 (제 1저자; IF 9.5)
2. National trends in asthma prevalence in South Korea before and during the COVID-19 pandemic, 1998-2021. Clin Exp Allergy. 2023 (제 1저자; IF 6.1)
1. Global and regional burden of vaccine-induced thrombotic thrombocytopenia, 1969–2023: Comprehensive findings with critical analysis of the international pharmacovigilance database. Eur J Haematol. 2024 (교신저자; IF 3.1)
슬라이드3.PNG
김현진 Hyeon Jin Kim, PhD Researcher, hyeonjin7418@gmail.com
데이터 사이언스, 디지털헬스, 의료빅데이터, 인공지능, 임상시험

· 수상이력

2026 한빛사 11회 선정
2026 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2025-2026 KHU Presidential Research Fellowship
2024-2025 Research Fellow, Massachusetts General Hospital & Harvard Medical School 
2025 대학원대통령과학장학금 장학생 선발 (박사)
2025 한국연구재단 이공분야 학술연구지원사업(박사과정생연구장려금지원) 선정 / 연구책임자
2025 제2회 미래 규제과학 신진연구자 대상 수상
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 아산사회복지재단 보건의료정책분야 장학생 선발 (석사)
2024 경희대학교 우수학위논문상 수상 (석사)
2023 사회적가치연구원 (CSES) 펠로우 6기 / 우수펠로우 
2023 인공지능융합혁신인재양성 자율과제 선정 / 팀리더

· 논문

2026
29. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study. Nat Med. 2026 (제 1저자; IF 50.0)
28. Maternal Opioid Use and Subsequent Risk of Allergic Diseases in Children: Emulation of Target Trials Using the Korean Nationwide Birth Cohort. Allergy. 2026 (제 1저자; IF 12.0)
27. Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program. Prog Cardiovasc Dis. 2026 (제 1저자; IF 7.6) 
26. Gestational Diabetes Mellitus and Adverse Maternal and Neonatal Health Outcomes: an Umbrella review of Meta-Analyses. Obes Rev. 2026 (제 1저자; IF 7.4)
25. Genetic confounding in the association between obesity-related phenotypes and neuropsychiatric disorders. J Affect Disord. 2026 (제 1저자; IF 4.9)
24. Step counts over time with the burden of 105 non-communicable diseases in older adults from the All of Us Program. Arch Gerontol Geriatr. 2026 (제 1저자; IF 3.8)

2025
23. Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study. eClinicalMedicine. 2025 (교신저자; IF 9.6)
22. Global, regional and national trends in suicide mortality rates across 102 countries from 1990 to 2021 with projections up to 2050. Nat. Ment. Health. 2025 (교신저자; IF 8.7)
21. Final Report on the Safety and Efficacy of Poly-L-Lactic Acid Filler (Gana V) Injection for the Correction of Nasolabial Fold: A Double-Blind, Non-Inferiority, Randomized, Split-Face Controlled Trial. Aesthetic Plast Surg. 2025 (제 1저자; IF 2.8)
20. Prospective Efficacy of Cutotype-Specific Personalized Topical Postbiotic Emollients in Females: A Single-Center, Cluster-Based, Pre-Post, Nonrandomized Controlled Trial in South Korea. J Cosmet Dermatol. 2025 (제 1저자; IF 2.3)
19. Association of Everyday Discrimination With Drug Use During the COVID-19 Pandemic in the All of Us Research Program. Psychiatry Investig. 2025 (제 1저자)

2024
18. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. BMJ. 2024 (제 1저자; IF 107.7)
17. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nat Commun. 2024 (제 1저자; IF 16.6)
16. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024 (제 1저자; IF 16.6)
15. Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
14. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK. J Med Virol. 2024 (교신저자; IF 12.7)
13. Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild-to-moderate atopic dermatitis: A randomized, double-blind, vehicle-controlled trial. Allergy. 2024 (제 1저자; IF 12.4)
12. Comorbid health outcomes in patients with schizophrenia: an umbrella review of systematic reviews and meta-analyses. Mol Psychiatry. 2024 (제 1저자; IF 9.6)
11. National prevalence and trends in food labeling awareness, comprehension, usage, and COVID-19 pandemic-related factors in South Korea, 2014-2022. Sci Rep. 2024 (교신저자; IF 4.6)
10. Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study. Sci Rep. 2024 (제 1저자; IF 4.6)
9. Global, Regional, and National Burden of Spine Pain, 1990-2019: A Systematic Analysis of the Global Burden of Disease Study 2019. Arch Phys Med Rehabil. 2024 (제 1저자; IF 4.3)
8. Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: A nationwide birth cohort study in South Korea. Psychiatry Res. 2024 (제 1저자; IF 4.2)
7. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019. Eur Rev Med Pharmacol Sci. 2024 (교신저자; IF 3.3)
6. Post Hoc Non-inferiority Analysis of the Efficacy of Poly-L-Lactic Acid Filler (Gana V versus Sculptra) Injection for Correction of the Nasolabial Fold: A Double-Blind, Randomized, Split-Face Controlled Trial. Aesthetic Plast Surg. 2024 (제 1저자; IF 2.0)

2023
5. National Trends in Physical Activity Among Adults in South Korea Before and During the COVID-19 Pandemic, 2009-2021. JAMA Netw Open. 2023 (제 1저자; IF 13.8)
4. National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea. J Med Virol. 2023 (제 1저자; IF 12.7)
3. National trends in the prevalence of chronic kidney disease among Korean adults, 2007-2020. Sci Rep. 2023 (제 1저자; IF 4.6)
2. Safety and Efficacy of Poly-L-Lactic Acid Filler (Gana V vs. Sculptra) Injection for Correction of the Nasolabial Fold: A Double-Blind, Non-Inferiority, Randomized, Split-Face Controlled Trial. Aesthetic Plast Surg. 2023 (제 1저자; IF 2.7)
1. Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea. Eur Rev Med Pharmacol Sci. 2023 (제 1 저자; IF 3.3)
슬라이드1.PNG
이하연 Hayeon Lee, PhD Researcher, wwhy28@khu.ac.kr
생체의공학, 생체신호, 디지털헬스, 의료빅데이터, 인공지능

· 수상이력

2025 Research Fellow, New York University 
2025 31문화재단 장학생 선발 (박사)
2025 대학원대통령과학장학금 장학생 선발 (박사)
2024 대한민국 인재상 수상
2024 한빛사 15회 선정
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 31문화재단 장학생 선발 (석사)
2024 경희대학교 우수학위논문상 수상 (석사)
2024 대한의료정보학회장상 수상
2024 EAACI Congress Award (유럽알레르기면역학회) 수상
2024 83회 일본예방의학회 International Award 수상
2024 제 31회 대한기초의학 학술대회 / 우수 구연상 수상
2024 경희대학교 2024 제 5회 고황스콜라 학술제 / 우수 구연상 수상
2023 보건장학재단 장학생 선발
2023 인공지능융합혁신인재양성 자율과제 선정 / 팀리더
2022 딥노이드 AI 코딩대회 우승

· 논문

2025
36. Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study. Nat Med. 2026 (제 1 저자; IF 50.0)
35. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. (교신저자; IF 38.1)
34. Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study. Circulation. (교신저자; IF 37.8)
33. Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial. Allergy. (교신저자; IF 12.0)
32. Effectiveness of the live zoster vaccine in patients with type 2 diabetes: A nationwide emulated target trial. Clin Microbiol Infect. (교신저자; IF 10.9)
31. Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study. EClinicalMedicine. (제 1저자; IF 9.6)
30. Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study. J Med Virol. (교신저자; IF 6.8)
29. Post-Acute Sequelae of COVID-19 on Alopecia Areata in Individuals With Mental Illness in South Korea and Japan: A Binational Population-Based Cohort Study. J Med Virol. (교신저자; IF 6.8)
28. Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea. J Med Virol. (교신저자; IF 6.8)
27. Artificial intelligence models predicting abnormal uterine bleeding after COVID-19 vaccination. Sci Rep. (교신저자; IF 3.8)
26. Global burden of vaccine-associated kidney injury using an international pharmacovigilance database Sci Rep. (제 1저자; IF 3.8)
25. Burden of post-acute sequelae of COVID-19 in patients with type 2 diabetes: a binational cohort study in South Korea and Japan. Int J Infect Dis. (교신저자; IF XX)
24. Long-term effectiveness of live zoster vaccine against herpes zoster and related complications: a nationwide emulated target trial in South Korea. Vaccine(교신저자; IF 3.5)

2024
23. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19: A Binational Cohort Study. Ann Intern Med. 2024 (교신저자; IF 39.2)
22. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat Hum Behav (교신저자; IF 29.9)
21. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nat Commun. 2024 (교신저자; IF 16.6)
20. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024 (교신저자; IF 16.6)
19. Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multi-nationwide cohort study from South Korea, Japan, and the UK. Clin Mol Hepatol. 2024 (교신저자; IF 14.0)
18. Global burden of vaccine-associated angioedema and their related vaccines, 1967-2023: Findings from the global pharmacovigilance database. Allergy. 2024 (교신저자; IF 12.7)
17. Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan. J Med Virol. 2024 (교신저자; IF 12.7)
16. Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database. J Med Virol. 2024 (교신저자; IF 12.7)
15. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK. J Med Virol. 2024 (교신저자; IF 12.7)
14. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
13. Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database. Allergy. 2024 (제 1저자; IF 12.4)
12. Global burden of vaccine-associated alopecia, 1979-2023: a comprehensive analysis of the international pharmacovigilance database. Br J Dermatol. 2024 (교신저자; IF 10.1)
11. Risks of chronic urticaria following SARS-CoV-2 infection: binational population-based cohort studies from South Korea and Japan. J Allergy Clin Immunol Pract. 2024 (교신저자; IF 9.4)
10. Machine Learning-Based Prediction of Suicidality in Adolescents With Allergic Rhinitis: Derivation and Validation in 2 Independent Nationwide Cohorts. J Med Internet Res. 2024 (교신저자; IF 7.4)
9. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023. J Med Virol. 2024 (교신저자; IF 6.8)
8. Machine Learning-Based Prediction for Incident Hypertension Based on Regular Health Checkup Data: Derivation and Validation in 2 Independent Nationwide Cohorts in South Korea and Japan. J Med Internet Res. 2024 (제 1저자; IF 5.8)
7. Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort. Sci Rep. 2024 (제 1저자; IF 4.6)
6. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023. Sci Rep. 2024 (교신저자; IF 4.6)
5. Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database. Allergy Asthma Immunol Res. 2024 (교신저자; IF 4.1)
4. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database. Med Princ Pract. 2024 (교신저자; IF 2.9)
3. Assessing the interplay of contrast, defocus, and resolution in cryo-EM: a benchmark experiment for limited dataset screening. J Anal Sci Technol. 2024 (제 1저자; IF 2.4)

2023
2. Machine learning-based prediction of suicidality in adolescents during the COVID-19 pandemic (2020-2021): Derivation and validation in two independent nationwide cohorts. Asian J Psychiatr. 2023 (제 1저자; IF 9.5)
1. Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial. Alzheimers Res Ther. 2023 (제 1저자; IF 9.0)